Surmodics, Inc. (SRDX)

Surmodics Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	121.58	126.08	132.58	99.95	105.14	94.86
Revenue Growth (YoY)	-14.96%	-4.91%	32.65%	-4.93%	10.83%	-5.21%
Cost of Revenue	30.79	33.03	24.97	20.34	17.68	65.51
Gross Profit	90.78	93.05	107.62	79.61	87.46	29.36
Selling, General & Admin	52.93	53.14	51.88	46.94	31.58	28.39
Research & Development	38.36	38.36	46.6	50.61	48.93	-
Operating Expenses	94.76	95	102.02	101.69	83.3	30.61
Operating Income	-3.97	-1.95	5.6	-22.09	4.16	-1.25
Interest Expense	-3.5	-3.54	-3.49	-0.6	-0.31	-0.13
Interest & Investment Income	1.56	1.92	1.08	0.1	0.12	0.66
Currency Exchange Gain (Loss)	-0.16	-0.24	-0.25	0.1	-0.17	-0.25
Other Non Operating Income (Expenses)	-	-	-	-	-	0
EBT Excluding Unusual Items	-6.07	-3.81	2.94	-22.48	3.8	-0.98
Merger & Restructuring Charges	-8.5	-3.7	-1.28	-	-1.05	-
Gain (Loss) on Sale of Investments	-	-	-	-	-	-0.48
Other Unusual Items	-	-	0.83	-0.01	3.6	-
Pretax Income	-14.57	-7.51	2.49	-22.49	6.35	-1.45
Income Tax Expense	5.29	4.04	4.02	4.78	2.11	-2.58
Earnings From Continuing Operations	-19.86	-11.54	-1.54	-27.27	4.24	1.12
Net Income	-19.86	-11.54	-1.54	-27.27	4.24	1.12
Net Income to Common	-19.86	-11.54	-1.54	-27.27	4.24	1.12
Net Income Growth	-	-	-	-	277.29%	-85.21%
Shares Outstanding (Basic)	14	14	14	14	14	14
Shares Outstanding (Diluted)	14	14	14	14	14	14
Shares Change (YoY)	0.91%	0.87%	0.83%	-0.52%	1.28%	0.24%
EPS (Basic)	-1.40	-0.82	-0.11	-1.96	0.31	0.08
EPS (Diluted)	-1.40	-0.82	-0.11	-1.96	0.30	0.08
EPS Growth	-	-	-	-	275.00%	-85.45%
Free Cash Flow	-7.44	-3.24	7.6	-20.59	10.11	10.34
Free Cash Flow Per Share	-0.52	-0.23	0.54	-1.48	0.72	0.75
Gross Margin	74.67%	73.80%	81.17%	79.65%	83.19%	30.95%
Operating Margin	-3.27%	-1.54%	4.23%	-22.10%	3.95%	-1.32%
Profit Margin	-16.34%	-9.16%	-1.16%	-27.29%	4.03%	1.18%
Free Cash Flow Margin	-6.12%	-2.57%	5.73%	-20.60%	9.62%	10.90%
EBITDA	4.51	6.75	14.13	-12.94	12.17	6.01
EBITDA Margin	3.71%	5.35%	10.65%	-12.95%	11.58%	6.34%
D&A For EBITDA	8.49	8.69	8.52	9.14	8.02	7.26
EBIT	-3.97	-1.95	5.6	-22.09	4.16	-1.25
EBIT Margin	-3.27%	-1.54%	4.23%	-22.10%	3.95%	-1.32%
Effective Tax Rate	-	-	161.76%	-	33.23%	-
Revenue as Reported	121.58	126.08	132.58	99.95	105.14	94.86

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q